150 related articles for article (PubMed ID: 34225211)
1. The role of QT-prolonging medications in a forensic autopsy study from Western Denmark.
Ahmed H; Larsen MK; Hansen MR; Andersen CU
Forensic Sci Int; 2021 Aug; 325():110889. PubMed ID: 34225211
[TBL] [Abstract][Full Text] [Related]
2. Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium.
Vandael E; Marynissen T; Reyntens J; Spriet I; Vandenberghe J; Willems R; Foulon V
Int J Clin Pharm; 2014 Aug; 36(4):757-65. PubMed ID: 24805801
[TBL] [Abstract][Full Text] [Related]
3. [QTc-prolonging drugs and the risk of sudden death].
Reingardiene D; Vilcinskaite J
Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine and other antipsychotics combined with opioids in legal autopsy cases: A random finding or cause of fatal outcome?
Andersen FD; Simonsen U; Andersen CU
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):66-79. PubMed ID: 33245632
[TBL] [Abstract][Full Text] [Related]
5. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
Rochoy M; Auffret M; Béné J; Gautier S;
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
[TBL] [Abstract][Full Text] [Related]
6. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.
De Ponti F; Poluzzi E; Montanaro N
Eur J Clin Pharmacol; 2000 Apr; 56(1):1-18. PubMed ID: 10853872
[TBL] [Abstract][Full Text] [Related]
7. Genetic factors contribute to medication-induced QT prolongation: A review.
Toba-Oluboka T; Tibbo PG; Dempster K; Alda M
Psychiatry Res; 2022 Nov; 317():114891. PubMed ID: 36257205
[TBL] [Abstract][Full Text] [Related]
8. Frequency of high-risk use of QT-prolonging medications.
Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
[TBL] [Abstract][Full Text] [Related]
9. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
De Ponti F; Poluzzi E; Cavalli A; Recanatini M; Montanaro N
Drug Saf; 2002; 25(4):263-86. PubMed ID: 11994029
[TBL] [Abstract][Full Text] [Related]
10. [Psychopharmaceuticals and arrhythmias].
Binggeli C; Candinas R; Brunckhorst C
Ther Umsch; 2004 Apr; 61(4):279-83. PubMed ID: 15137522
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
Khan Q; Ismail M; Haider I; Khan F
Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
[TBL] [Abstract][Full Text] [Related]
12. Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs.
Pezo RC; Yan AT; Earle C; Chan KK
Heart; 2019 Nov; 105(21):1649-1655. PubMed ID: 31129611
[TBL] [Abstract][Full Text] [Related]
13. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.
Das B; Rawat VS; Ramasubbu SK; Kumar B
Therapie; 2019 Dec; 74(6):599-609. PubMed ID: 31053339
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients.
Khan Q; Ismail M; Haider I; Ali Z
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):109-115. PubMed ID: 29458991
[TBL] [Abstract][Full Text] [Related]
15. Fatality due to amisulpride toxicity: a case report.
Lynch MJ; Woods J; George N; Gerostamoulos D
Med Sci Law; 2008 Apr; 48(2):173-7. PubMed ID: 18533580
[TBL] [Abstract][Full Text] [Related]
16. QTc prolongation, torsades de pointes, and psychotropic medications.
Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced long QT syndrome in women.
Li G; Cheng G; Wu J; Zhou X; Liu P; Sun C
Adv Ther; 2013 Sep; 30(9):793-802. PubMed ID: 24085659
[TBL] [Abstract][Full Text] [Related]
18. Proarrhythmic drugs, drug levels, and polypharmacy in victims of sudden arrhythmic death syndrome: An autopsy-based study from Denmark.
Palsøe MK; Hansen CJ; Torp-Pedersen C; Winkel BG; Linnet K; Tfelt-Hansen J; Banner J
Heart Rhythm; 2024 May; ():. PubMed ID: 38735633
[TBL] [Abstract][Full Text] [Related]
19. [Risk management of QT-prolonging drugs by community pharmacists using a mobile electrocardiograph].
Shinozaki K
Yakugaku Zasshi; 2010 Nov; 130(11):1597-601. PubMed ID: 21048421
[TBL] [Abstract][Full Text] [Related]
20. Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality.
Weeke PE; Kellemann JS; Jespersen CB; Theilade J; Kanters JK; Hansen MS; Christiansen M; Marstrand P; Gislason GH; Torp-Pedersen C; Bundgaard H; Jensen HK; Tfelt-Hansen J
Eur Heart J; 2019 Oct; 40(37):3110-3117. PubMed ID: 31079148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
